Academic or other sponsor

New York State Psychiatric Institute

12 registered trials on this registry. An academic sponsor is usually answering a scientific question rather than seeking approval, which changes what its trials are designed to show.

Registered trials

Recruiting

In Phase 3

With results posted

Working on

Substances

Trials

All 12 trials

Trial	Status	Phase	Substance	Sites
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsNCT07139106 · New York State Psychiatric Institute	Not yet recruiting	Phase 4	ketamine	1
IM Ketamine vs Midazolam for Suicidal ER PatientsNCT04640636 · New York State Psychiatric Institute	Suspended	Phase 4	ketamine	1
Ketamine Treatment Effects on Synaptic Plasticity in DepressionNCT04091971 · New York State Psychiatric Institute	Completed	Phase 4	ketamine	1
Ketamine in the Treatment of Suicidal DepressionNCT01700829 · New York State Psychiatric Institute	Completed	Phase 4	ketamine	1
NMDA Antagonists in Bipolar DepressionNCT01833897 · New York State Psychiatric Institute	Completed	Phase 4	ketamine	1
Safety and Efficacy of Psilocybin for Body Dysmorphic DisorderNCT04656301 · New York State Psychiatric Institute	Completed	Phase 2	psilocybin	1
Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)NCT02422290 · New York State Psychiatric Institute	Completed	Phase 1 / Phase 2	ketamine	1
Ketamine for Suicidality in Bipolar DepressionNCT01944293 · New York State Psychiatric Institute	Completed	Phase 1 / Phase 2	ketamine	1
Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive DisorderNCT00956085 · New York State Psychiatric Institute	Completed	Phase 2	ketamine	1
Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCDNCT02206776 · New York State Psychiatric Institute	Terminated	Phase 2	ketamine	1
Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)NCT01100255 · New York State Psychiatric Institute	Completed	Phase 2	ketamine	1
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)NCT02062658 · New York State Psychiatric Institute	Completed	Phase 2	ketamine	1

Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.